talazoparib,enzalutamide
pfizer,astellas
['crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'talazo', 'enzalu', 'talapro-2', 'enzalutamide']
talapro-2: talazoparib+enzalutamide in mcrpc unselected for hrr status vs pbo+enzalutamide, n=805; med rpfs by bicr: nr vs 21.9 mo; hr=0.63. all prespecified subgroups benefited by addition of tala including non-hrr deficient. os immature #gu23 #mcrpc #parp
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to share the latest heme/onc news with  clinicians and educators